ArticleJHLT open2025
One-year lung transplantation outcomes for engineered stone countertop workers with silicosis at a single center in Southern California, 2019 to 2023.
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Silicosis and silica dust sampling in mineral mining across 30 countries: a systematic review and meta-analysis.BMC public health · 2026Pooled it
- New exposure, ancient disease: patient experiences with artificial stone silicosis.Annals of the American Thoracic Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the past decade, growing industrial exposure to respirable crystalline silica from manufacturing engineered stone (ES) products has caused rapidly progressive, irreversible silicosis worldwide. Consequently, there has been a recent surge in lung transplants for ES silicosis but few reports of post-transplant outcomes. We compared perioperative and 1-year post-transplant outcomes for silicosis and nonsilicosis interstitial lung disease (ILD) recipients at UC San Diego (UCSD) Health. Methods: Using the electronic health record and United Network for Organ Sharing database, we identified 7 patients with silicosis and 69 with nonsilicosis ILD who underwent double lung transplantation at UCSD from 2019-2023. We compared pretransplant, perioperative, and 1-year post-transplant outcomes between groups. Results: Recipients with silicosis were younger than those with nonsilicosis ILD (43.1 ± 9.9 vs 59.3 ± 7.1 years; Conclusions: Though reflecting a failure of prevention, lung transplantation should be considered as a therapeutic option for patients with end-stage silicosis from exposure to ES.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.